Isotechnika Pharma Inc IPHAF

RE: "Alleged failure to disclose" , " misleading".

[ISAloser247]

...on the ISA website, under Corporate Overview section? it was pointed out to me , that in the Phase 3 Clinical Program section, they are still touting that "importantly" funding for part one of trial ( 20+ million ) is secured by Iljin agreement.  Being an  ISA cognac sniffer for numerous years, and knowing of problems of 'unresolved issues' with management , keeping the website up to date is .........oh  f*** it........................................